Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Amarin Corporation stock in Canada | $4.45

Own Amarin Corporation shares in just a few minutes.

Amarin Corporation is a biotechnology business based in the US. Amarin Corporation stocks (AMRN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.45 – a decrease of 1.98% over the previous week. Amarin Corporation employs 1,000 staff and has a trailing 12-month revenue of around $601.2 million.

How to buy Amarin Corporation stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: AMRN in this case.
  5. Research Amarin Corporation stocks. The platform should provide the latest information available.
  6. Buy your Amarin Corporation stocks. It's that simple.

How has Coronavirus impacted Amarin Corporation's stock price?

Since the stock market crash in March caused by coronavirus, Amarin Corporation's stock price has had significant negative movement.

Its last market close was $4.45, which is 75.18% down on its pre-crash value of $17.93 and 92.81% down on the lowest point reached during the March crash when the stocks fell as low as $8.58.

If you had bought $1,000 worth of Amarin Corporation stocks at the start of February 2020, those stocks would have been worth $573.71 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $241.99.

Amarin Corporation stock price

Use our graph to track the performance of AMRN stocks over time.

Amarin Corporation stocks at a glance

Information last updated 2021-07-22.
Latest market close$4.45
52-week range$3.36 - $9.25
50-day moving average $4.5557
200-day moving average $5.6499
Wall St. target price$10.13
PE ratio 2059.9998
Dividend yield N/A (0%)
Earnings per share (TTM) $0.002

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Get a $50 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$4.99-$9.99
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$0
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$6.95
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are greater than or equal to US$10.00)
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95-$9.95
$9.95 + $1 per contract
$0
Free
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Trade 100 select ETFs free of charge.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Amarin Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Amarin Corporation price performance over time

Historical closes compared with the last close of $4.45

1 month (2021-06-23) -1.98%

Is Amarin Corporation under- or over-valued?

Valuing Amarin Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amarin Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amarin Corporation's P/E ratio

Amarin Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2060x. In other words, Amarin Corporation stocks trade at around 2060x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stocks or simply that they're over-valued.

Amarin Corporation's EBITDA

Amarin Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$5.1 million.

The EBITDA is a measure of a Amarin Corporation's overall financial performance and is widely used to measure a its profitability.

Amarin Corporation financials

Revenue TTM USD$601.2 million
Operating margin TTM 0.51%
Gross profit TTM USD$482.6 million
Return on assets TTM 0.2%
Return on equity TTM 0.15%
Profit margin 0.15%
Book value $1.608
Market capitalisation USD$1.6 billion

TTM: trailing 12 months

How to short and sell Amarin Corporation stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "AMRN.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 23.5 million Amarin Corporation stocks held short by investors – that's known as Amarin Corporation's "short interest". This figure is 6.1% down from 25.1 million last month.

There are a few different ways that this level of interest in shorting Amarin Corporation stocks can be evaluated.

Amarin Corporation's "short interest ratio" (SIR)

Amarin Corporation's "short interest ratio" (SIR) is the quantity of Amarin Corporation stocks currently shorted divided by the average quantity of Amarin Corporation stocks traded daily (recently around 3.4 million). Amarin Corporation's SIR currently stands at 6.83. In other words for every 100,000 Amarin Corporation stocks traded daily on the market, roughly 6830 stocks are currently held short.

However Amarin Corporation's short interest can also be evaluated against the total number of Amarin Corporation stocks, or, against the total number of tradable Amarin Corporation stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amarin Corporation's short interest could be expressed as 0.06% of the outstanding stocks (for every 100,000 Amarin Corporation stocks in existence, roughly 60 stocks are currently held short) or 0.0655% of the tradable stocks (for every 100,000 tradable Amarin Corporation stocks, roughly 66 stocks are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the stock price, with fewer people currently willing to bet against Amarin Corporation.

Find out more about how you can short Amarin Corporation stock.

Amarin Corporation stock dividends

We're not expecting Amarin Corporation to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.

Have Amarin Corporation stocks ever split?

Amarin Corporation stocks were split on a 1:10 basis on 18 January 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin Corporation stocks – just the quantity. However, indirectly, the new 900% higher stock price could have impacted the market appetite for Amarin Corporation stocks which in turn could have impacted Amarin Corporation's stock price.

Amarin Corporation stock price volatility

Over the last 12 months, Amarin Corporation's stocks have ranged in value from as little as $3.36 up to $9.25. A popular way to gauge a stock's volatility is its "beta".

AMRN.US volatility(beta: 2.24)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin Corporation's is 2.2421. This would suggest that Amarin Corporation's stocks are significantly more volatile than the average for this exchange and represent a higher risk.

Amarin Corporation overview

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site